| Effect of treatment with magnesium and potassium on mortality and reinfarction rate of patients with suspected acute myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 8738859 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The aim of the study was to test whether magnesium and potassium administration can decrease both early and late cardiac event rates in 355 patients with suspected acute myocardial infarction (AMI). The study was conducted by a primary and secondary care research centre as a randomized, initially double-blind comparison for 4 weeks followed by a single blind period for 2 years. Patients with definite or possible AMI and unstable angina based on World Health Organization criteria were assigned within 24 hours of infarction to different groups. Treatment was administered for 3 days through intravenous infusion with either 8.12 mmol/day Mg (group A, n = 81), 10.49 mmol/day K (group B, n = 77) 10% dextrose solution (group C, n = 87) or a placebo containing 2% dextrose solution (group D, n = 81). After discharge from the hospital all groups were advised to follow a fat-reduced diet. Groups A, B, and C were also advised to take magnesium hydroxide or potassium chloride orally. Comparison of groups A and B with group D over 2 years indicated that treatment with magnesium or potassium was associated with increased (p < 0.05) serum magnesium and potassium, and significant reduction in the incidence of cardiac events (22 and 24 vs 41 patients), total mortality (9 and 10 vs 20 deaths), and ventricular ectopics (17 and 21 vs 44), respectively, in the groups. Group C showed no significant benefit. It is possible that magnesium and potassium infusion immediately after AMI and addition of Mg and K salts to the AMI regimen may enhance tissue levels of these cations, leading to significant reduction in complications and mortality after 2 years. |
| | |
Authors:
|
R B Singh; N K Singh; M A Niaz; J P Sharma |
Related Documents
:
|
18412239 - Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: propen... 17307419 - Intracoronary beta-irradiation for the treatment of de novo lesions: 5-year clinical fo... 22947159 - Clinical and clinicopathologic abnormalities in young dogs with acquired and congenital... 22036539 - Arthroscopic treatment of septic arthritis of the elbow. 20850089 - Thrombosis of second-generation drug-eluting stents in real practice results from the m... 20484099 - Long-term outcome of adjunctive celecoxib treatment after paclitaxel-eluting stent impl... 19567759 - Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. 11552889 - Stent placement in short unilateral iliac occlusion. technique and 24-month results. 2619149 - The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mas... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial |
Journal Detail:
|
Title: International journal of clinical pharmacology and therapeutics Volume: 34 ISSN: 0946-1965 ISO Abbreviation: Int J Clin Pharmacol Ther Publication Date: 1996 May |
Date Detail:
|
Created Date: 1996-10-25 Completed Date: 1996-10-25 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9423309 Medline TA: Int J Clin Pharmacol Ther Country: GERMANY |
Other Details:
|
Languages: eng Pagination: 219-25 Citation Subset: IM |
Affiliation:
|
Heart Research Laboratory, Medical Hospital and Research Centre, Moradabad, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Aspartate Aminotransferases / blood Blood Pressure / physiology Creatine Kinase / metabolism Double-Blind Method Electrocardiography Female Humans L-Lactate Dehydrogenase / blood Magnesium / therapeutic use* Male Middle Aged Myocardial Infarction / mortality, physiopathology, prevention & control* Potassium / therapeutic use* Recurrence Risk Factors Smoking |
| Chemical | |
Reg. No./Substance:
|
7439-95-4/Magnesium; 7440-09-7/Potassium; EC 1.1.1.27/L-Lactate Dehydrogenase; EC 2.6.1.1/Aspartate Aminotransferases; EC 2.7.3.2/Creatine Kinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Activation of protein tyrosine kinase: a possible requirement for fixed-bacteria and lipopolysacchar...
Next Document: Establishment of a reliable extraction method of estrone sulfate from bovine plasma for detection of...